✦ LIBER ✦

Sa1989 Pharmacokinetics of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Randomized, Multicenter, Open-Label Phase 3 Study

✍ Scribed by Adedokun, Omoniyi J.; Xu, Zhenhua; Damaraju, Lakshmi; Blank, Marion; Johanns, Jewel; Griffiths, Anne M.; Ford, Joyce A.; Zhou, Honghui; Guzzo, Cynthia A.; Davis, Hugh M.; Hyams, Jeffrey S.

Book ID: 122230558
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 90 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(12)61415-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Multicenter, Open-Label Ph

A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis

✍ Jeffrey S. Hyams; Lakshmi Damaraju; Marion Blank; Jewel Johanns; Cynthia Guzzo; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 519 KB

Sa1203 Pharmacokinetics and Exposure-Res

Sa1203 Pharmacokinetics and Exposure-Response Relationship of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase2/3 Induction and Maintenance Studies

✍ Adedokun, Omoniyi J.; Xu, Zhenhua; Marano, Colleen W; Strauss, Richard; Zhang, H 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 319 KB

OC.08.6 EFFICACY OF INFLIXIMAB IN “REAL

OC.08.6 EFFICACY OF INFLIXIMAB IN “REAL PRACTICE” PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A RETROSPECTIVE MULTICENTER STUDY FROM SOUTHERN ITALY

✍ Cappello, M.; Mazza, M.; Costantino, G.; Fries, W.; Privitera, A.; Mastronardi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Safety, tolerability, pharmacokinetics,

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study

✍ Edward M. Wolin, Ke Hu, Gareth Hughes… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 401 KB

A randomized, multicenter, multinational

A randomized, multicenter, multinational, phase 3B, open-label, parallel-group study of agalsidase beta in treatment-naive male pediatric patients with Fabry disease without severe symptoms: Baseline demographics and clinical data

✍ Wijburg, Frits; Bénichou, Bernard; Bichet, Daniel G.; Dostalova, Gabriela; Clark 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Long-term efficacy and safety of adalimu

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB